Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Nov 08 04:00PM ET
46.23
Dollar change
-1.38
Percentage change
-2.90
%
IndexRUT P/E17.60 EPS (ttm)2.63 Insider Own5.52% Shs Outstand57.71M Perf Week-1.13%
Market Cap2.72B Forward P/E- EPS next Y-1.57 Insider Trans-2.20% Shs Float55.65M Perf Month6.06%
Income169.95M PEG- EPS next Q-0.56 Inst Own101.30% Short Float5.39% Perf Quarter13.87%
Sales319.12M P/S8.53 EPS this Y267.96% Inst Trans17.04% Short Ratio4.95 Perf Half Y63.76%
Book/sh9.21 P/B5.02 EPS next Y-167.43% ROA36.35% Short Interest3.00M Perf Year189.48%
Cash/sh9.57 P/C4.83 EPS next 5Y- ROE40.69% 52W Range14.78 - 48.89 Perf YTD101.61%
Dividend Est.- P/FCF11.80 EPS past 5Y4.38% ROI30.77% 52W High-5.44% Beta2.20
Dividend TTM- Quick Ratio13.73 Sales past 5Y2462.45% Gross Margin98.94% 52W Low212.79% ATR (14)1.85
Dividend Ex-Date- Current Ratio13.73 EPS Y/Y TTM204.10% Oper. Margin47.71% RSI (14)49.55 Volatility6.15% 3.61%
Employees112 Debt/Eq0.02 Sales Y/Y TTM36565.08% Profit Margin53.26% Recom1.00 Target Price54.38
Option/ShortYes / Yes LT Debt/Eq0.02 EPS Q/Q26.28% Payout- Rel Volume1.12 Prev Close47.61
Sales Surprise32.63% EPS Surprise16.02% Sales Q/Q- EarningsAug 06 BMO Avg Volume606.81K Price46.23
SMA20-1.55% SMA501.52% SMA20031.78% Trades Volume680,884 Change-2.90%
Date Action Analyst Rating Change Price Target Change
Nov-05-24Initiated Wedbush Outperform $58
Sep-24-24Initiated TD Cowen Buy $65
Sep-09-24Initiated Truist Buy $60
Oct-30-23Initiated CapitalOne Overweight $32
May-25-23Resumed Jefferies Buy $30 → $40
Aug-25-22Initiated JMP Securities Mkt Outperform $21
Feb-11-22Initiated BTIG Research Buy $55
Oct-12-21Upgrade JP Morgan Neutral → Overweight $49 → $55
Oct-11-21Upgrade Northland Capital Market Perform → Outperform $40
Sep-20-21Downgrade JP Morgan Overweight → Neutral $60 → $49
Nov-07-24 05:30PM
04:56PM
04:05PM
Nov-05-24 04:05PM
Oct-29-24 09:27AM
06:28AM Loading…
Oct-18-24 06:28AM
Oct-16-24 03:03PM
Sep-10-24 01:17PM
Sep-03-24 07:30AM
Aug-06-24 01:53PM
08:20AM
07:18AM
07:00AM
Aug-01-24 08:00AM
07:00AM
09:15AM Loading…
Jul-31-24 09:15AM
Jul-22-24 07:00AM
Jul-18-24 08:50AM
Jul-11-24 06:00AM
Jun-28-24 04:07PM
12:11PM
Jun-27-24 05:44PM
01:43PM
Jun-26-24 10:12PM
Jun-14-24 03:00AM
Jun-05-24 01:35PM
May-31-24 07:30AM
May-14-24 04:05PM
May-07-24 11:53PM
09:04PM
04:23PM Loading…
04:23PM
04:10PM
04:05PM
Apr-16-24 09:00AM
Apr-05-24 12:00PM
Apr-03-24 01:52AM
Mar-26-24 07:00AM
Mar-18-24 09:55AM
07:00AM
Mar-11-24 07:00AM
Mar-06-24 04:05PM
Mar-01-24 12:20PM
12:00PM
12:00PM
09:55AM
08:50AM
Feb-27-24 04:38PM
04:05PM
Feb-21-24 05:00PM
Feb-20-24 04:05PM
Feb-15-24 03:13AM
Feb-07-24 05:00PM
Feb-02-24 01:03PM
Feb-01-24 06:35AM
Jan-31-24 04:05PM
Jan-29-24 07:30AM
Jan-12-24 03:02AM
Jan-03-24 07:30AM
Dec-16-23 11:01AM
Dec-13-23 07:30AM
Dec-12-23 09:04AM
Nov-27-23 09:00AM
Nov-16-23 04:05PM
05:50AM
Nov-09-23 03:55PM
09:55AM
Nov-04-23 05:42AM
Nov-02-23 06:24PM
04:05PM
09:05AM
Nov-01-23 04:05PM
07:30AM
Oct-30-23 04:05PM
Oct-09-23 07:00AM
Oct-03-23 04:05PM
Sep-05-23 07:30AM
Aug-16-23 04:05PM
Aug-09-23 07:00AM
Aug-03-23 04:48PM
04:05PM
Jul-18-23 04:05PM
Jul-05-23 09:33AM
Jul-04-23 03:30AM
Jun-30-23 08:50AM
Jun-15-23 09:55AM
Jun-13-23 08:50AM
Jun-09-23 08:05AM
Jun-06-23 07:30AM
Jun-01-23 04:01PM
May-26-23 09:55AM
May-12-23 03:14PM
07:00AM
May-11-23 04:05PM
10:17AM
May-05-23 04:03PM
May-04-23 05:02PM
04:05PM
Apr-20-23 09:51PM
Apr-17-23 06:35AM
Apr-04-23 10:45PM
Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, which engages in discovering and developing peptide-based therapeutic drugs to address unmet medical needs. Its product pipeline includes PTG-300, PTG-200, and PN-943. The company was founded by Mark L. Smythe on August 22, 2006 and is headquartered in Newark, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ali AsifChief Financial OfficerSep 11 '24Option Exercise15.6812,000188,16046,960Sep 13 04:35 PM
Ali AsifChief Financial OfficerSep 11 '24Sale44.4914,203631,87234,960Sep 13 04:35 PM
Waddill William D.DirectorSep 10 '24Option Exercise12.888,000103,04020,000Sep 12 07:38 PM
Waddill William D.DirectorSep 10 '24Sale45.008,000360,00012,000Sep 12 07:38 PM
Ali AsifOfficerSep 11 '24Proposed Sale44.4914,203631,855Sep 11 06:15 PM
WILLIAM D WADDILLDirectorSep 10 '24Proposed Sale45.008,000360,000Sep 10 04:17 PM
Waddill William D.DirectorJul 24 '24Option Exercise12.888,000103,04020,000Jul 26 04:31 PM
Waddill William D.DirectorJul 24 '24Sale40.008,000320,00012,000Jul 26 04:31 PM
Waddill William D.DirectorJun 07 '24Option Exercise12.888,000103,04020,000Jun 11 04:30 PM
Waddill William D.DirectorJun 07 '24Sale35.008,000280,00012,000Jun 11 04:30 PM
PATEL DINESH V PH DPresident and CEOJun 07 '24Sale35.1935,0001,231,650515,415Jun 11 04:30 PM
Ali AsifChief Financial OfficerApr 18 '24Sale25.111,23430,98637,163Apr 19 08:05 PM
PATEL DINESH V PH DPresident and CEOApr 01 '24Sale28.3125,000707,750549,590Apr 02 08:29 PM
SELICK HAROLD EDirectorMar 07 '24Option Exercise1.896,49012,26627,996Mar 11 08:00 PM
PATEL DINESH V PH DPresident and CEOMar 01 '24Sale31.6230,000948,600574,590Mar 01 08:46 PM
Waddill William D.DirectorMar 01 '24Option Exercise6.0912,97579,01824,975Mar 01 08:45 PM
Waddill William D.DirectorMar 01 '24Sale31.3412,975406,63612,000Mar 01 08:45 PM
Ali AsifChief Financial OfficerMar 01 '24Option Exercise12.1712,000146,04052,645Mar 01 08:45 PM
Ali AsifChief Financial OfficerMar 01 '24Sale32.2414,248459,31838,397Mar 01 08:45 PM
Ali AsifChief Financial OfficerFeb 29 '24Sale30.699,939305,04840,645Mar 01 08:45 PM
Gupta SuneelChief Development OfficerJan 09 '24Option Exercise7.385,00036,900192,567Jan 11 08:00 PM
Gupta SuneelChief Development OfficerJan 09 '24Sale25.005,000125,000187,567Jan 11 08:00 PM
MOLINA ARTURO MDChief Medical OfficerNov 15 '23Sale16.241,84830,01222,527Jan 04 08:09 PM
PATEL DINESH V PH DPresident and CEODec 13 '23Sale20.0875,0001,506,000534,347Dec 15 04:30 PM